Albert Font

Albert Font

CEO

Leanbio

About me

Leanbio is a cutting-edge CDMO specializing in recombinant proteins, antibodies, bioconjugates, and mRNA. With both microbial and mammalian production platforms, the company deliver seamless, end-to-end biopharmaceutical development and manufacturing services. The company offers tailored cell line development solutions for a broad range of protein types, from standard monoclonal antibodies to complex and novel biologics.

Social media

Contact details

Is member of

Leanbio
Exhibitors

is attending

Eidolon Learning - Start-Up Pitch

Tuesday, October 24, 2023 9:00 AM to 9:15 AM
Start-Up Market, 3QS, Hall 3

Fast, Insight Driven Process Development with Hybrid Modeling and Knowledge Transfer

Tuesday, October 24, 2023 9:00 AM to 9:30 AM
BioProduction Content - 3C49

Reactor simulations made accurate, fast and easy

BioProduction Content - 3C49

Building a Collaborative Supply Chain for Biological Products: A Roadmap for the Future

Tuesday, October 24, 2023 9:40 AM to 10:00 AM
CPHI Content Hub - CC4.3

Business Continuity Management in the Biologic Industry Supply Chain: an Industry Best Practice Approach

BioProduction Content - 3C49

Log in

See all the content and easy-to-use features by logging in or registering!